Researchers conducted a retrospective chart review of 78 patients with severe obesity (class III, BMI ≥ 35 to < 40 or class IV, BMI ≥ 40; mean BMI, 39.9; 51% men) who underwent direct current ...

ROME, ITALY — Using the factor Xa inhibitor edoxaban (Savaysa/Lixiana, Daiichi Sankyo) to anticoagulate patients about to undergo electrical cardioversion for their atrial fibrillation (AF) seems ...